Edited by Rossella Parini, Francesca Santamaria, Maurizio Scarpa, Andrea Biondi, Generoso Andria and Giancarlo Parenti
Volume 44 Supplement 2
Mucopolysaccharidoses: state of the art
Reviews
The publication costs for this supplement were made possible with unconditional financial support from BioMarin, Sanofi Genzyme, and Shire. The sponsors had no input into the content of articles, which were independently prepared by the authors and have undergone the journal’s standard peer-review process. RP has received reimbursements, fees and funding, from Sanofi Genzyme, Shire International, BioMarin, Ultragenyx, SOBI and Chiesi. FS is a Senior Editor of Italian Journal of Pediatrics, and declares no competing interests. MS has received honoraria for scientific expertise and seminars and research grants from Actelio, Biomarin, Chiesi, Sanofi Genzyme, SHIRE , Sangamo and Ultragenix. GA declares no competing interests. AB declares no competing interests. GP declares no competing interests.
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Annual Journal Metrics
-
Speed
56 days to first decision for reviewed manuscripts only
45 days to first decision for all manuscripts
109 days from submission to acceptance
16 days from acceptance to publicationCitation Impact
1.776 - 2-year Impact Factor
1.963 - 5-year Impact Factor
1.048 - Source Normalized Impact per Paper (SNIP)
0.685 - SCImago Journal Rank (SJR)Usage
471,324 Downloads
282 Altmetric Mentions
Advertisement
